Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Magenta Therapeutics Inc (MGTA)

Magenta Therapeutics Inc (MGTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,441
  • Shares Outstanding, K 60,665
  • Annual Sales, $ 0 K
  • Annual Income, $ -76,460 K
  • EBIT $ -78 M
  • EBITDA $ -77 M
  • 60-Month Beta 2.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.57
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.32
  • Most Recent Earnings $-0.05 on 08/03/23
  • Next Earnings Date 11/02/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +370,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6810 +2.73%
on 09/11/23
0.8300 -15.71%
on 08/14/23
-0.1054 (-13.09%)
since 08/11/23
3-Month
0.6200 +12.84%
on 06/21/23
0.8500 -17.69%
on 08/03/23
-0.0006 (-0.09%)
since 06/09/23
52-Week
0.3210 +117.94%
on 12/21/22
2.0650 -66.12%
on 09/13/22
-1.2304 (-63.75%)
since 09/09/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, FRG, EMAN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MGTA : 11.1936 (-7.74%)
FRG : 29.88 (+0.10%)
EMAN : 2.07 (+2.99%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MGTA : 11.1936 (-7.74%)
STSA : 1.1000 (-0.90%)
Moore Kuehn Encourages RUTH, MGTA, MDWT, and CBOF Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

RUTH : 21.49 (+0.05%)
MGTA : 11.1936 (-7.74%)
MDWT : 26.99 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RUTH : 21.49 (+0.05%)
MGTA : 11.1936 (-7.74%)
OPCH : 22.15 (+1.23%)
AMED : 90.05 (+0.06%)
Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus

/PRNewswire/ -- Ademi LLP is investigating Magenta (Nasdaq: MGTA) for possible breaches of fiduciary duty and other violations of law in its transaction with...

MGTA : 11.1936 (-7.74%)
MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Magenta Therapeutics, Inc. (NasdaqGM: MGTA)...

MGTA : 11.1936 (-7.74%)
MGTA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Magenta Therapeutics, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Magenta Therapeutics, Inc. (NASDAQ: MGTA) and Dianthus Therapeutics, Inc. is fair to Magenta shareholders. Upon completion...

MGTA : 11.1936 (-7.74%)
Pre-Market Brief: Stocks Mostly Higher Ahead of Key U.S. Inflation Data

December S&P 500 futures (ESZ22) are trending up +0.25% this morning after three major US benchmark indices finished the regular session higher as market participants took an optimistic stance ahead of...

ESZ22 : 3,871.47s (-0.66%)
MSFT : 413.60 (-0.26%)
LSEG.LN : 10,990.000 (+0.83%)
MGTA : 11.1936 (-7.74%)
ORCL : 194.90 (+2.18%)
MRTX : 58.70 (-0.17%)
NCLH : 26.44 (+1.54%)
ACMR : 18.94 (+1.39%)
Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights

– MGTA-117 Phase 1/2 clinical trial progress continues and remains consistent with earlier observations of target binding, target cell reductions, rapid...

MGTA : 11.1936 (-7.74%)
Magenta Therapeutics to Participate in Panel Discussion at the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel...

MGTA : 11.1936 (-7.74%)

Business Summary

Magenta Therapeutics Inc. is a clinical-stage biotechnology company. It engaged in developing therapeutics focused on critical areas of unmet need in the field of bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. Magenta Therapeutics Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 0.8232
2nd Resistance Point 0.7911
1st Resistance Point 0.7453
Last Price 11.1936
1st Support Level 0.6674
2nd Support Level 0.6353
3rd Support Level 0.5895

See More

Last Price 11.1936
52-Week High 2.0650
Fibonacci 61.8% 1.3988
Fibonacci 50% 1.1930
Fibonacci 38.2% 0.9872
52-Week Low 0.3210

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar